SmithJBHellwigKFinkK, et al. Rituximab, MS, and pregnancy. Neurol Neuroimmunol Neuroinflamm2020; 7: e734.
2.
CanibanoBAliMMesraouaB, et al. Severe rebound disease activity after fingolimod withdrawal in a pregnant woman with multiple sclerosis managed with rituximab: A case study. Case Rep Womens Health2020; 25: e00162.
3.
HollenCRiceJParkM, et al. Rituximab for treatment of refractory multiple sclerosis relapses during pregnancy. Mult Scler2021.
4.
HaghikiaALanger-GouldARellensmannG, et al. Natalizumab use during the third trimester of pregnancy. JAMA Neurol2014; 71: 891–895.
5.
NielsenASMiravalleALanger-GouldA, et al. Maximally tolerated versus minimally effective dose: The case of rituximab in multiple sclerosis. Mult Scler2012; 18: 377–378.
